An Epidemiologic Study of Xolair (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS)

Grants and Contracts Details

StatusFinished
Effective start/end date7/29/044/30/12

Funding

  • Genentech Inc: $102,025.00